Chemed Remains A Buy On Long-Term Economics

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment update Following my last publication on Chemed Corporation (NYSE:CHE) the stock is flat, and I am reiterating my buy rating on the stock after its Q2 FY'24 earnings. The last publication, titled "Continues to compound shareholder value at double-digit returns" advocated to size into CHE based on a number of factors, all of which are still relevant today, namely: CHE is a long-term compounder with a cycle of producing high returns on th ...